Association Between Apolipoprotein E ∊4 and Sleep-Disordered Breathing in Adults

Authors:
  • TKTomiko Kadotani
    Tomiko Kadotani
  • TYTerry Young
    Terry Young
  • PPPaul E. Peppard
    Paul E. Peppard
  • LFLaurel Finn
    Laurel Finn
  • ICIan M. Colrain
    Ian M. Colrain
  • JMJr Greer M. Murphy
    Jr Greer M. Murphy
  • EMEmmanuel Mignot
    Emmanuel Mignot

Abstract
Research from JAMA — Association Between Apolipoprotein E ∊4 and Sleep-Disordered Breathing in Adults — ContextApolipoprotein E ∊4 (ApoE ∊4) is a well-known risk factor for Alzheimer disease and cardiovascular disease. Sleep-disordered breathing occurs in Alzheimer disease patients and increases risks for cardiovascular disease. Complex interactions among sleep, brain pathology, and cardiovascular disease may occur in ApoE ∊4 carriers.ObjectiveTo study whether genetic variation at the level of ApoE is associated with sleep-disordered breathing or sleep abnormalities in the general population.Design, Setting, and ParticipantsOngoing longitudinal cohort study of sleep disorders at a US university beginning in 1989, providing a population-based probability sample of 791 middle-aged adults (mean [SD] age, 49 [8] years; range, 32-68 years).Main Outcome MeasureNocturnal polysomnography to evaluate apnea-hypopnea index.ResultsThe probability of moderate-to-severe sleep-disordered breathing (apnea-hypopnea index ≥15%) was significantly higher in participants with ∊4, independent of age, sex, body mass index, and ethnicity (12.0% vs 7.0%; P = .003). Mean (SEM) apnea-hypopnea index was also significantly higher in participants with ApoE ∊4 (6.5 [0.6] vs 4.8 [0.3]; P = .01). These effects increased with the number of ApoE ∊4 alleles carried.ConclusionsA significant portion of sleep-disordered breathing is associated with ApoE ∊4 in the general population.